financing

News

Eikon, Veradermics close IPOs, as Salspera joins queue

Eikon and Veradermics push upsized IPOs over the line, as Salspera, which is developing live microbial immunotherapies for cancer, seeks a listing.

News

Three more biotechs price their Nasdaq IPOs

AgomAb, SpyGlass, and Veradermics have all set the terms for their IPOs this week, looking to raise somewhere between around $150m and $200m.

News

Eikon prices its IPO, seeking to raise $318m

Roger Perlmutter's new cancer biotech Eikon has priced its IPO, looking to raise up to $318m and achieve a $900m-plus valuation.

News

UK biotech sees "strong finish" to 2025 financing

2025 was a challenging year for the UK biotech sector, but it ended the year with signs of "renewed confidence," says the BIA industry body.

News

Corxel's raises $287m for obesity drug, and other financings

Our latest biofinancing round-up sees big rounds for Corxel and Caldera, with Mendra, Think Bio, Exciva, Cytotheryx, and Infinitopes also raising cash

News

AgomAb and SpyGlass push the IPO button

Glimmers of a renewal of biotech IPO activity in 2026 have continued with the news that AgomAb and SpyGlass Pharma are sizing up investor interest.

Eikon, Veradermics close IPOs, as Salspera joins queue

Three more biotechs price their Nasdaq IPOs

Eikon prices its IPO, seeking to raise $318m

UK biotech sees "strong finish" to 2025 financing

Corxel's raises $287m for obesity drug, and other financings

AgomAb and SpyGlass push the IPO button

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

financing

Editor's Picks